At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,014 enrolled
Drug / intervention
No Screeningother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Does Screening for Gonorrhea and Chlamydia Affect the Incidence of These Infections in Men Who Have Sex With Men Taking HIV Pre Exposure Prophylaxis (PrEP): a Randomized, Multicentre Controlled Trial
In Brief
A clinical study evaluating No Screening for Neisseria Gonorrhoeae Infection and Chlamydia Trachomatis Infection. Completed, enrolled 1,014 participants across 5 sites.
Detailed Summary
A Multicentre, controlled, randomized trial of 3 site (urethra, pharynx and rectum) sampling performed every 3 months (3x3) for Neisseria gonorrhoea (Ng)/Chlamydia trachomatis (Ct) screening (comparator) vs. no screening (intervention).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesBelgium
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedFeb 2020
Enrollment StartSep 2020
Primary CompletionAug 2022
TodayJul 2026
First PostedFeb 13, 2020
Enrollment StartSep 21, 2020
Primary CompletionAug 31, 2022
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 6.4 years ago
Interventions
No Screeningother
the STI Laboratory will only process the samples/report the results from the non-screening arm at the end of the study.